MedPath

The effect of exercise induced extra-thoracic airway obstruction on end expiratory lung volume in children.

Withdrawn
Conditions
Exercise induced airway obstruction
Exercise induced asthma
10046304
Registration Number
NL-OMON32324
Lead Sponsor
Medisch Spectrum Twente
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion criteria (asthmatic subjects)
- Clinical history of allergic rhinitis and/or allergic asthma.
- Age between 12 and 17 years.
- Ability to perform reproducible lung function tests, i.e. coefficient of the predicted
value variation in 3 of 5 consecutive measurements < 5%.
- Maximal FEV1 greater than 70% of predicted value.
- Clinically stable period at least 3 weeks before the study period. ;Inclusion criteria (healthy subjects)
- No currently reported illnesses.
- Age between 12 and 17 years.
- Ability to perform reproducible lung function tests, i.e. coefficient of the predicted
value variation in 3 of 5 consecutive measurements < 5%.
- Maximal FEV1 greater than 70% of predicted value.
- Clinically stable period at least 3 weeks before the study period.

Exclusion Criteria

Exclusion criteria (asthmatic subjects)
- Use of intranasal or systemic corticosteroids in the last 4 weeks prior to the study.
- Use of antihistamines, cromoglycates, anticholinergics in two weeks prior to the study.
- Use of long acting bronchodilators 24 hours before testing.
- Use of short acting bronchodilators 8 hours before testing.
- Other pulmonary or cardiac disorder.
- Deviation of the FEV1 of more than 12 % from baseline spirometry and the FEV1 before subsequent exercise provocation challenges.
- Signs of gastro-esophageal reflux. ;Exclusion criteria (healthy subjects)
- Reported Illness in the past.
- Exhaled NO of more than 20 ppb
- Signs of gastro-esophageal reflux.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The study endpoint will be the end of the exercise provocation test, where<br /><br>change in MIF50 will be linked to change in EELV. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath